G&GTK |News



G&GTK | New milestone

We are completing a capital increase with the renewed support of our long-standing investor, Proxis Développement, once again confirming their confidence in our vision, our team, and our trajectory.

This milestone sends a strong signal for what’s ahead: accelerating our growth, strengthening our ambitions, and continuing to move forward with determination. 


G&GTK | On the Front Page

Our latest review article is on the front page of the Journal of Agricultural and Food Chemistry 


G&GTK | In the spotlight

Raphaël Billot received the IFPEN-ANRT award for its PhD work with Gene&GreenTK. Watch the interview !


About us

G&GTK is a science-driven biotech company created in 2013 and incubated in the Hospital Institute of Marseille.

Technology

The work of G&GTK is dedicated to the development and engineering of robust enzymes isolated from microorganisms living in extreme environments.

Applications

Enzymes developed by G&GTK have two main applications:

 

  • Anti-virulence and anti-biofilm for the development of novel medical devices, anti-fouling paintings or coatings and biobased materials
  • Decontamination of organophosphorus chemicals including insecticides and warfare nerve agents.


Harnessing the potential of enzymes